<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H88BF0A040E144E94AD0A0F283DADA69C" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 2325 IH: To amend title XVIII of the Social Security Act to provide for a pharmaceutical and technology ombudsman under the Medicare program.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-05-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code> 
<congress>114th CONGRESS</congress>
<session>1st Session</session>
<legis-num>H. R. 2325</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20150514">May 14, 2015</action-date> 
<action-desc><sponsor name-id="B001284">Mrs. Brooks of Indiana</sponsor> (for herself and <cosponsor name-id="B001257">Mr. Bilirakis</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HWM00">Committee on Ways and Means</committee-name>, and in addition to the Committee on <committee-name committee-id="HIF00">Energy and Commerce</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc>
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To amend title XVIII of the Social Security Act to provide for a pharmaceutical and technology ombudsman under the Medicare program.</official-title> 
</form> 
<legis-body id="H1E16F41F8919423F9CEEC4E41316D652" style="OLC"> 
<section id="HD79F9568C6CA4BCD82C2A8A7B7A1B006" section-type="section-one"><enum>1.</enum><header>Medicare pharmaceutical and technology ombudsman</header><text display-inline="no-display-inline">Section 1808(c) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395b-9">42 U.S.C. 1395b–9(c)</external-xref>) is amended by adding at the end the following new paragraph:</text> <quoted-block style="OLC" id="HF59ED2AC04014993B21D1A6A54A61BCC" display-inline="no-display-inline"> <paragraph id="H42A85EA73B354C6482E466ECCDBC1D6A"><enum>(4)</enum><header>Pharmaceutical and technology ombudsman</header><text display-inline="yes-display-inline">Not later than 12 months after the date of the enactment of this paragraph, the Secretary shall provide for a pharmaceutical and technology ombudsman within the Centers for Medicare &amp; Medicaid Services who shall receive and respond to complaints, grievances, and requests that—</text> 
<subparagraph id="HAFE79F8612324F5BB1B5F20E723B6590"><enum>(A)</enum><text display-inline="yes-display-inline">are from entities that manufacture pharmaceutical, biotechnology, medical device, or diagnostic products that are covered or for which coverage is being sought under this title; and</text></subparagraph> <subparagraph id="H0B99EA75658642EA8D5352826D317D51"><enum>(B)</enum><text>regard coverage, coding, or payment under this title for such products.</text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></section> 
</legis-body> 
</bill> 


